These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6523419)
1. [Treatment of peptic ulcer of the gastroduodenal area with the antioxidant dibunol and the change in antioxidant activity of erythrocyte lipids in patients during treatment]. Korochkin IM; Bashkatova VG; Poslavskiĭ MV Ter Arkh; 1984; 56(12):88-90. PubMed ID: 6523419 [TBL] [Abstract][Full Text] [Related]
2. [Effect of the antioxidant dibunol on hemostatic parameters in patients with non-healing ulcers]. Podoprigorova VG; Khibin LS; Barcel' VA; Kogan IG; Anokhina EI; Sidorenkova EN Klin Med (Mosk); 1996; 74(1):43-5. PubMed ID: 8649008 [TBL] [Abstract][Full Text] [Related]
4. [Use of the antioxidant dibunol for the local treatment of gastroduodenal ulcers]. Korochkin IM; Poslavskiĭ MV Sov Med; 1983; (12):102-4. PubMed ID: 6673136 [No Abstract] [Full Text] [Related]
5. [Effectiveness of synthetic antioxidants in treatment of patients with peptic ulcer (an open randomized controlled trial)]. Podoprigorova VG; Khibin LS; Kozlov NB; Barsel' VA Klin Med (Mosk); 1999; 77(3):32-5. PubMed ID: 10234944 [TBL] [Abstract][Full Text] [Related]
6. [Effect of the antioxidant dibunol on the composition and lipid peroxidation intensity of the blood of ischemic heart disease patients]. Sal'nikov MI; Barsel' VA; Arkhipova GV Dokl Akad Nauk SSSR; 1984; 278(3):747-51. PubMed ID: 6499651 [No Abstract] [Full Text] [Related]
8. [Lipid peroxidation products in the blood of patients with acute myocardial infarction treated and untreated with the antioxidant dibunol]. Churakova TD; Bileko MV; Pokazeeva ZT; Zaslavskaia RM; Polumiskov VIu Vestn Akad Med Nauk SSSR; 1985; (4):71-4. PubMed ID: 4013513 [No Abstract] [Full Text] [Related]
9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study. Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114 [TBL] [Abstract][Full Text] [Related]
10. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing. Hsu CC; Lu SN; Changchien CS Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer]. Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725 [TBL] [Abstract][Full Text] [Related]
12. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
13. [Efficiency of quamatel in combination with device sound stimulation of the gastroduodenal zone in ulcer patients]. Maev IV; Samsonov A; Val'tova ED; Ismailova MZ; Ovchinnikova NI Klin Med (Mosk); 2001; 79(8):51-5. PubMed ID: 11588788 [TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of erosive-ulcerous disorders of the upper gastrointestinal tract with dibunol]. Emanuél' NM; Andrianova OP; Sokolov LK; Korman DB; Krutova TV Sov Med; 1986; (6):96-9. PubMed ID: 3750058 [No Abstract] [Full Text] [Related]
16. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine]. Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198 [TBL] [Abstract][Full Text] [Related]
17. [Correction of biochemical disorders in the lipid metabolism of atherosclerosis patients by using the antioxidant dibunol]. Barsel' VA; Korochkin IM; Arkhipova GV; Sal'nikov MI; Matveeva SA Izv Akad Nauk SSSR Biol; 1988; (1):75-85. PubMed ID: 3351102 [No Abstract] [Full Text] [Related]
18. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
19. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease. Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]